PBS dispute could see MS patients pay thousands for crucial drugs Ocrevus and Kesimpta
A dispute over how Australia prices medicines has sparked fears 10,000 people with multiple sclerosis will be forced…
WHO Guidance, GLP-1 Price Curbs Unlikely to Change Practice
A new World Health Organization (WHO) guideline recommending GLP-1s for obesity treatment along with recent efforts to reduce…